Healios K.K. entered into an asset purchase agreement to acquire Substantially all assets of ABT Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million.

Healios K.K. (TSE:4593) entered into an asset purchase agreement to acquire Substantially all assets of Abt Holding Company, Advanced Biotherapeutics, Inc, Athersys, Inc. (OTCPK:ATHX.Q), ReGenesys BVBA and ReGenesys, LLC for $2.8 million on January 5, 2024. The transaction is subjected to the regulatory approvals, antitrust regulations, approval of bankruptcy court, approval of both buyers' board of directors and approval of target's board of directors. Nicholas M. Miller and Michael J. Kaczka of McDonald Hopkins Co.

LPA acted as legal advisor to Athersys. Seth J. Kleinman and Adam Lewis of Morrison & Foerster LLP acted as legal advisor to Healios. Ellen Baron of Outcome Capital, LLC acted as financial advisor to Outcome Capital, LLC.